Dianne Wells
Nurse Practitioner · Mashpee, MANPI 1083899678
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 433 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,639 and has fallen 96.0% since, to $106 in 2025. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 433 payments — averaging $20.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$772
- Lilly USA, LLC$699
- Pfizer$556
- Johnson & Johnson$496
- Abbott$413
- plus $4K from 31 others
What the payments were for
- Food & beverage$8,743100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 93 | $1,893 |
| Novo Nordisk | 43 | $772 |
| Lilly USA, LLC | 38 | $699 |
| Pfizer | 35 | $556 |
| Johnson & Johnson | 9 | $496 |
| Abbott | 20 | $413 |
| AstraZeneca | 20 | $397 |
| Nestle Healthcare Nutrition Inc. | 18 | $388 |
| Bayer | 16 | $371 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $363 |
| Merck | 14 | $259 |
| Amgen | 8 | $227 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $217 |
| Indivior Inc. | 8 | $198 |
| Biohaven Pharmaceuticals, Inc. | 12 | $193 |
| GSK | 6 | $129 |
| Alnylam Pharmaceuticals Inc. | 5 | $106 |
| Kowa Pharmaceuticals America, Inc. | 7 | $105 |
| Corium, LLC | 5 | $103 |
| Phathom Pharmaceuticals, Inc. | 5 | $101 |
| Acerus Pharmaceuticals Corporation | 5 | $88 |
| Lundbeck LLC | 4 | $77 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $73 |
| Dexcom, Inc. | 3 | $65 |
| Paratek Pharmaceuticals, Inc. | 3 | $64 |
| Novartis | 3 | $61 |
| Amarin Pharma, Inc. | 3 | $52 |
| Bausch Health US, LLC | 2 | $42 |
| Medtronic | 2 | $42 |
| Inspire Medical Systems, Inc. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Genentech USA, Inc. | 2 | $34 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Lucid Diagnostics Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,743 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 34 | $44,847 |
| TrulicityDulaglutide | 18 | $30,232 |
| JanuviaSitagliptin Phosphate | 15 | $20,705 |
| LivaloPitavastatin Calcium | 13 | $7,672 |
| Rosuvastatin Calcium | 95 | $5,472 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 26 | $3,224 |
| RitalinMethylphenidate Hcl | 11 | $2,635 |
| SynthroidLevothyroxine Sodium | 31 | $2,460 |
| Wixela InhubFluticasone Propion/Salmeterol | 15 | $2,210 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 37 | $1,751 |
| Fluoxetine Hcl | 34 | $1,711 |
| Atorvastatin Calcium | 77 | $1,314 |
| Losartan Potassium | 63 | $1,240 |
| Buspirone Hcl | 19 | $1,112 |
| Oxycodone Hcl | 62 | $1,021 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $772 | $44,84734 claims |
| Lilly USA, LLCTrulicity | $699 | $30,23218 claims |
| MerckJanuvia | $259 | $20,70515 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $105 | $7,67213 claims |
| AbbVieSynthroid | $1,893 | $2,46031 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Other nurse practitioner in Mashpee
- Lauri WelchNorth Chelmsford$110K
- Teresa FogarenBoston$102K
- Carolyn MetivierBoston$93K
- Deborah GearySalem$80K
- Amberly ChaplinWorcester$56K
- Darlene MadoreBrockton$42K
- Nancy SydowN Chelmsford$35K
- Miu Lai NgBoston$33K
- Victoria Garcia AlbeaStoneham$31K
- Lauren BurkeBoston$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.